Goal #6: Enhance training programs 

Mentorship is critical for career and skill development in clinical and translational research, but locating practical resources on how to initiate, build, maintain, and assess these relationships is often challenging. To fill this gap, Harvard Catalyst has developed a new guide with popular resources adapted from their course and program content to help both mentees and mentors at all career stages maximize their relationships and grow their networks. Read the full article <a href="https://catalyst.harvard.edu/mentorship-in-clinical-and-translational-research/" target="_blank" rel="noopener noreferrer">here</a>.

Harvard Clinical and Translational Science Center

Harvard Catalyst. Mentorship in Clinical and Translational Research. A guide to empower mentees and mentors in maximizing their mentoring relationships and growing their networks.

large_harvard mentorship.PNG

medium_harvard mentorship.PNG

small_harvard mentorship.PNG

thumbnail_harvard mentorship.PNG

harvard mentorship.PNG

Harvard Medical School

Harvard Clinical and Translational Science Center's New Guide on Mentorship in Clinical and Translational Research

- Any -

Goal #1: Advance clinical and translational science

A person’s use of health care services before a COVID-19 infection may be the strongest predictor of whether they will get long COVID after an infection. These findings are according to a study of electronic health records (EHRs) from 55,257 people in the <a href="https://ncats.nih.gov/research/research-activities/n3c/overview" target="_blank" rel="noopener noreferrer">National Clinical Cohort Collaborative (N3C)</a> database. The study results could help clinicians better focus preventive efforts on people at greater risk for getting long COVID.&nbsp;Researchers at the University of California, Berkeley, and their colleagues conducted their study as part of the NIH <a href="https://www.challenge.gov/?challenge=l3c" target="_blank" rel="noopener noreferrer">Long COVID Computational Challenge</a>. Long COVID includes a range of long-term symptoms that people have after acute COVID-19. The N3C database has EHRs from more than 8 million people who have had COVID-19…&nbsp;Read the full article <a href="https://ncats.nih.gov/news-events/news/n3c-study-shows-health-factors-covid-19-infection-may-predict-long-covid-risk" target="_blank" rel="noopener noreferrer">here</a>.

National Institutes of Health (NIH)

medium_NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

small_NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

thumbnail_NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

NCATS_RECOVER-Study-Long-COVID-Social-Promo-Image_1000x500px.jpg

National Center for Advancing Translational Sciences

N3C Study Shows Health Factors Before COVID-19 Infection May Predict Long COVID Risk

X-logo-teal_80x66.png

ri_linkedin_fill_408497d4b5_96748f4451.png

Living kidney donation, in which a living person donates one kidney to another in need, offers the best outcomes for many kidney patients. However, the pool of living donors is limited, partly due to the exclusion of potential donors with a high body mass index (BMI).&nbsp;Next month, researchers from the University of Texas Medical Branch (UTMB) and Houston Methodist will launch a new study aimed at developing recommendations and tools to support ethical and equitable decisions about living donation by potential donors with high BMIs…&nbsp;Read the full article <a href="https://www.utmb.edu/its/welcome/news/2024/08/29/ethics-of-screening-for-obesity-in-organ-donation" target="_blank" rel="noopener noreferrer">here</a>.

CTSA CCOS

Home

About

CTSA Groups and Meetings

Resources

News

Help

CTSA News

Date

Share this News Post

Harvard Clinical and Translational Science Center's New Guide on Mentorship in Clinical and Translational Research